Secondary analysis of a placebo-controlled trial: in 24 women with refractory rosacea given paroxetine for 12 weeks, mean erythema score fell from 3.1 to 2.3. Exploratory plasma proteomics found 497 candidate altered proteins; OLFML3 predicted response (AUC 0.87).
Secondary analysisn = 24
Wang et al. Systemic Proteomic Alterations and Predictive Biomarkers of Paroxetine Response in Refractory Rosacea: A Secondary Analysis of a Randomized Clinical Trial